JP2019513139A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513139A5
JP2019513139A5 JP2018550588A JP2018550588A JP2019513139A5 JP 2019513139 A5 JP2019513139 A5 JP 2019513139A5 JP 2018550588 A JP2018550588 A JP 2018550588A JP 2018550588 A JP2018550588 A JP 2018550588A JP 2019513139 A5 JP2019513139 A5 JP 2019513139A5
Authority
JP
Japan
Prior art keywords
solution
cyclodextrin
panobinostat
adduct
csf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018550588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513139A (ja
JP6880058B2 (ja
Filing date
Publication date
Priority claimed from GBGB1610440.8A external-priority patent/GB201610440D0/en
Application filed filed Critical
Priority claimed from PCT/EP2017/057472 external-priority patent/WO2017167837A1/en
Publication of JP2019513139A publication Critical patent/JP2019513139A/ja
Publication of JP2019513139A5 publication Critical patent/JP2019513139A5/ja
Application granted granted Critical
Publication of JP6880058B2 publication Critical patent/JP6880058B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018550588A 2016-03-31 2017-03-29 シクロデキストリン−パノビノスタット付加物 Active JP6880058B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB201605406 2016-03-31
GB1605406.6 2016-03-31
GB1610440.8 2016-06-15
GBGB1610440.8A GB201610440D0 (en) 2016-06-15 2016-06-15 Pharmaceutical formulations
PCT/EP2017/057472 WO2017167837A1 (en) 2016-03-31 2017-03-29 Cyclodextrin-panobinostat adduct

Publications (3)

Publication Number Publication Date
JP2019513139A JP2019513139A (ja) 2019-05-23
JP2019513139A5 true JP2019513139A5 (https=) 2019-06-27
JP6880058B2 JP6880058B2 (ja) 2021-06-02

Family

ID=58489304

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018550588A Active JP6880058B2 (ja) 2016-03-31 2017-03-29 シクロデキストリン−パノビノスタット付加物

Country Status (12)

Country Link
US (2) US10722597B2 (https=)
EP (1) EP3347055B1 (https=)
JP (1) JP6880058B2 (https=)
KR (1) KR102416050B1 (https=)
CN (1) CN109310783B (https=)
AU (2) AU2017242544B2 (https=)
CA (1) CA3018923A1 (https=)
ES (1) ES2743740T3 (https=)
MX (1) MX374165B (https=)
PL (1) PL3347055T3 (https=)
PT (1) PT3347055T (https=)
WO (1) WO2017167837A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019000342A (es) * 2016-07-08 2019-09-04 Ranedis Pharmaceuticals Llc Composiciones y metodos para tratar y/o prevenir enfermedades de almacenamiento lisosomal y otras enfermedades metabolicas monogeneticas.
EP3560492B1 (en) * 2016-12-26 2023-11-29 FUJIFILM Corporation Lipid particle composition and pharmaceutical composition
GB202020359D0 (en) 2020-12-22 2021-02-03 Midatech Pharma Wales Ltd Pharmaceutical compositions and use thereof in combination therapy for brain cancer
EP4577210A1 (en) 2022-08-26 2025-07-02 Biodexa Ltd. Combination therapy for brain cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278705A1 (en) 2000-08-10 2002-02-25 Takeda Chemical Industries Ltd. Pharmaceutical composition
JP4922507B2 (ja) * 2000-08-10 2012-04-25 武田薬品工業株式会社 医薬組成物
CN101189003B (zh) 2005-05-13 2012-02-08 托波塔吉特英国有限公司 Hdac抑制剂的药物制剂
US20070259031A1 (en) 2006-04-26 2007-11-08 The Regents Of The University Of California Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics
RU2009102275A (ru) 2006-06-26 2010-08-10 Новартис АГ (CH) Органические соединения
ITRM20070038A1 (it) * 2007-01-26 2008-07-27 Uni Degli Studi Di Roma La Sapienza Forme solubili di complessi di inclusione di inibitori dell istone deacetilasi e ciclodestrine loro processi di preparazione e impieghi in campo farmaceutico
CL2008002786A1 (es) * 2007-09-20 2009-05-15 Novartis Ag Torta farmceuticamente aceptable, formada por liofilizacion, que comprende: n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il]-etil]-amino]-metil]-fenil]-2e-2-propenamida o una sal, un regulador de ph seleciondo de lactato o acidop lactico, fodfato o acido fosforico o una combinacion y un agente de volumen; proceso de elaboracion.
GB201204263D0 (en) * 2012-03-12 2012-04-25 Renishaw Plc Giloma treatment
WO2015191931A1 (en) * 2014-06-12 2015-12-17 University Of Notre Dame Du Lac Composition and method for the treatment of neurological diseases and cerebral injury
GB201601773D0 (en) 2016-02-01 2016-03-16 Renishaw Plc Method

Similar Documents

Publication Publication Date Title
JP2019513139A5 (https=)
Lacroce et al. Polymer-based thermoresponsive hydrogels for controlled drug delivery
Iliff et al. Cerebral arterial pulsation drives paravascular CSF–interstitial fluid exchange in the murine brain
Imran et al. “Nanodecoys”-Future of drug delivery by encapsulating nanoparticles in natural cell membranes
Zhang et al. An injectable dipeptide–fullerene supramolecular hydrogel for photodynamic antibacterial therapy
JP2011519932A5 (https=)
EA201890836A1 (ru) Инъекционные составы нейростероида, содержащие наночастицы
Li et al. Dual‐modal NIR‐fluorophore conjugated magnetic nanoparticle for imaging amyloid‐β species in vivo
ES2991516T3 (es) Métodos para tratar tumores de restos adrenales testiculares y ováricos
CN105228652A (zh) 评价全脑血管旁路径的废弃物清除功能的方法以及基于这种方法治疗神经退化性病症的方法
JP2015535243A5 (https=)
JP2016539921A5 (https=)
AR072668A1 (es) Encapsulacion de agentes biologicamente activos
WO2016193810A8 (en) Formation of cyclosporin a/cyclodextrin nanoparticles
RU2014101036A (ru) Стабилизированная композиция вориконазола
Zhang et al. Therapeutic potential of injectable supramolecular hydrogels with neural stem cell exosomes and hydroxypropyl methylcellulose for post-stroke neurological recovery
Lu et al. PEGylated PAMAM dendrimer nanoplatform for co-delivery of chemotherapeutic agents and inorganic nanoparticles enhancing chemo-photothermal combination therapy
BR112013005763B1 (pt) Injeção de 5a-androstano-3ss, 5, 6ss-triol e método para prrparação da injeção
CN105769821B (zh) 他克莫司自组装聚合物纳米粒给药系统及其制备方法
AR074820A1 (es) Composicion de microparticulas biocompatibles de acido alginico para la liberacion controlada de principios activos por via intravenosa
MX374165B (es) Aducto de ciclodextrina-panobinostat
Cheng et al. DNA-based nanocomposites with secondary structure for precision treatment of tumor
RU2018128913A (ru) Инъекционная фармацевтическая композиция, включающая трабектедин, для применения вне желудочно-кишечного тракта и способ её получения
TWI616210B (zh) 經修飾微氣泡及其製備方法
Bal et al. Central nervous system imaging in diabetic cerebrovascular diseases and white matter hyperintensities